Nautilus Biotechnology, Inc.NAUT

$2.28+0.10 (+4.59%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$289M

Micro-cap

+19%

2020 — today

10-Year Price

-73%

2020 — today

52-Week Range

$0.64$3.95

Current $2.28· 50%

Nautilus Biotechnology, Inc. is an emerging life sciences firm dedicated to pioneering a platform technology aimed at quantifying and comprehensively understanding the intricate complexities of the proteome. Their flagship offering, the Nautilus Platform, is an integrated proteomics system. It provides a complete, end-to-end solution, including specialized instruments, essential consumables, and advanced software for data analysis. Based in Seattle, Washington, the company was established in 2016.

Valuation in context

P/E ratio

-5.0

N/A

Not meaningful — company is unprofitable

P/B ratio

2.0

Historically pricey

Historically pricey — last 10 years

FCF Yield

-17.8%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when NAUT is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.